TherapeuticsMD, Inc. is a pharmaceutical royalty company, which primarily collects royalties from its licensees. It receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. It granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
종목 코드 TXMD
회사 이름TherapeuticsMD Inc
상장일Jan 31, 2001
CEOMr. Marlan D. Walker, J.D.
직원 수1
유형Ordinary Share
회계 연도 종료Jan 31
주소951 Yamato Road, Suite 220
도시BOCA RATON
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호33431
전화15619611900
웹사이트https://www.therapeuticsmd.com/
종목 코드 TXMD
상장일Jan 31, 2001
CEOMr. Marlan D. Walker, J.D.
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음